Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and Taiwan
Clinical trial NCT03505008 · COMPLETED
Trial details
- NCT number
- NCT03505008
- Sponsor
- Keio University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-18
- Primary completion
- 2021-05-11
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.